Abstract
We analyzed the usefulness of mammaglobin, a breast-cancer-specific immunohistochemical marker, in cytological pleural effusion material. Pleural effusion was immunocytochemically stained for mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15) in 60 subjects, i. e., 20 cases each of breast cancer, lung cancer, and benign. Of breast cancer case fluid, 12 cases (60%) were immunoreactive for mammaglobin and 9 (45%) for GCDFP-15. Combining the two raised breast-cancer identification sensitivity to 70%. The specificity of mammaglobin was 100% and that of GCDFP-15 95%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of the Japanese Society of Clinical Cytology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
